medigraphic.com
SPANISH

Medicina Cutánea Ibero-Latino-Americana

ISSN 0210-5187 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2008, Number 4

Next >>

Med Cutan Iber Lat Am 2008; 36 (4)

Targeting the PPARs

Rodríguez-Martin M
Full text How to cite this article

Language: Spanish
References: 12
Page: 161-163
PDF size: 136.20 Kb.


Key words:

No keywords

Text Extraction

No abstract


REFERENCES

  1. 1.Michalik L, Desvergne B, Dreyer C, Gavillet M, Laurini R, Wahli W. PPAR expression and function during vertebrate development. Int J Dev Biol 2002;46:105-14.

  2. 2.Man M, Choi E, Schmuth M, Cumrine D, Uchida Y, Elías P et al. Basis for improved permeability Barrier Homeostasis induced by PPAR and LXR Activators: liposensors stimulate lípido síntesis, lamellar body secretion and post-secretory lípido processing. J Invest Dermatol 2006;126:386-92.

  3. Schmuth M, Jiang YJ, Dubrac S, Elias PM, Feingold KR. Thematic review series: skin lipids. Peroxisome proliferator activated receptors and liver X receptors in epidermal biology. J Lipid Res 2008;49:499-509.

  4. Feingold KR, Elias PM. The environmental interface. Regulation of permeability barrier homeostasis. En: Loden M, Maibach HI (eds). Dry Skin and Moisturizers: Chemistry and Function. Dermatology: Clinical and Basic Science Series. New York: CRC Press, 2000; pp. 45-58.

  5. 5.Schürer NY. Implementation of fatty acid Carriers to skin irritation and the epidermal barrier. Contact Dermatitis 2002;47:199-205.

  6. 6.Reddy RC. Immunomodulatory role of PPAR-gamma in alveolar macrophages. J Invest Med 2008;56:522-7.

  7. Staumont Sallé D, Abboud G, Brénuchon C, Kanda A, Roumier T, Lagoviez C et al. Peroxi-some proliferator-activated receptor alpha regulates skin inflammation and humoral response in atopic dermatitis. J Allergy Clin Immunol 2008;121:962-8.

  8. Behshad R, Cooper KD, Korman NJ. A retrospective case series review of the peroxisome proliferator-activated receptor ligand rosiglitazone in the treatment of atopic dermatitis. Arch Dermatol 2008;144: 84-8.

  9. Sertznig P, Seifert M, Tilgen W, Reichrath J. Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases. Am J Clin Dermatol 2008;9:15-31.

  10. Romanowska M, Al Yacoub N, Seidel H, Donandt S, Gerken H, Phillip S et al. PPARdelta enhances keratinocyte proliferation in psoriasis and induces heparin-binding EGFlike growth factor. J Invest Dermatol 2008;128:110-24.

  11. Igre G, Wahli W, Michalik L. Functions of the peroxisome proliferator-activated receptor (PPAR) alpha and beta in skin homeosta-sis, epithelial repair and morphogenesis. J Invest Dermatol Symp Proc 2006;11:30-5.

  12. Mössner R, Meyer P, Jankowski F, König IR, Krüger U, Kammerer S et al. Variations in the peroxisome proliferator —activated receptor gamma gene and melanoma risk. Cancer 2007;246:218-23.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Med Cutan Iber Lat Am. 2008;36